Richard S Levy's Net Worth

$51.4 Million

Estimate Recalculated Nov 11, 2024 08:19AM EST

Who is Richard S Levy?

Richard S Levy has an estimated net worth of $51.4 Million. This is based on reported shares across multiple companies, which include INCYTE CORP, MADRIGAL PHARMACEUTICALS, INC., CONSTELLATION PHARMACEUTICALS INC, Kiniksa Pharmaceuticals, Ltd., Kodiak Sciences Inc., AQUINOX PHARMACEUTICALS, INC, and Protara Therapeutics, Inc..

SEC CIK

Richard S Levy's CIK is 0001454983

Past Insider Trading and Trends

2014 was Richard S Levy's most active year for acquiring shares with 21 total transactions. Richard S Levy's most active month to acquire stocks was the month of May. 2015 was Richard S Levy's most active year for disposing of shares, totalling 34 transactions. Richard S Levy's most active month to dispose stocks was the month of December. 2023 saw Richard S Levy paying a total of $2,316,844.12 for 114,850 shares, this is the most they've acquired in one year. In 2014 Richard S Levy cashed out on 620,096 shares for a total of $19,448,485.73, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

INCYTE CORP (INCY) Snapshot price: $60.96

EVP, Chief Drug Dev Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$60.09
-$328,896.98
16.93K
Scheduled
Jan 6
Form 4
—
0
$62.25
-$345,904.82
16.93K
Scheduled
Dec 7
Form 4
—
0
$67.42
-$386,475.84
16.93K
Scheduled
Nov 6
Form 4
—
0
$70.31
-$409,329.89
16.93K
Scheduled
Oct 6
Form 4
-20.26%
-4.30K
$130.00
-$559,130.00
16.93K
Scheduled
Sep 11
Form 4
—
0
$68.61
-$395,983.46
21.23K
Scheduled
Sep 8
Form 4
—
0
$65.14
-$368,527.68
21.23K
Scheduled
Aug 6
Form 4
—
0
$68.90
-$7,176,879.57
21.23K
Scheduled
Jul 15
Form 4
—
0
$62.66
-$349,133.16
21.23K
Scheduled
Jul 6
Form 4
—
0
$62.96
-$1,806,800.00
21.23K
Scheduled
Jun 19
Form 4
—
0
$62.95
-$351,416.62
21.23K
Scheduled
Jun 8
Form 4
—
0
$58.88
-$601,187.32
21.23K
Scheduled
May 6
Form 4
—
0
$53.55
-$1,761,250.00
21.23K
Scheduled
Apr 6
Form 4
—
0
$54.11
-$1,789,750.00
21.23K
Scheduled
Mar 6
Form 4
—
0
$46.28
-$734,853.19
18.2K
Scheduled
Feb 17
Form 4
—
0
$46.72
-$1,419,750.00
18.2K
Scheduled
Feb 6
Form 4
—
0
$43.90
-$700,200.00
18.2K
Scheduled
Jan 16
Form 4
+16.60%
3.02K
—
—
21.23K
Jan 8
Form 4
—
0
$45.08
-$1,338,000.00
18.2K
Scheduled
Jan 6
Form 4
—
0
$43.54
-$691,680.00
18.2K
Scheduled
Dec 16
Form 4
—
0
$42.35
-$663,000.00
18.2K
Scheduled
Nov 17
Form 4
+323.27%
13.9K
$3.11
$43,241.44
18.2K
Oct 23
Form 4
—
0
$31.88
-$274,480.00
4.3K
Scheduled
Oct 16
Form 4
—
0
$31.15
-$262,880.00
4.3K
Scheduled
Sep 16
Form 4
—
0
$33.35
-$298,000.00
4.3K
Scheduled
Aug 18
Form 4
—
0
$31.44
-$267,440.00
4.3K
Scheduled
Jul 16
Form 4
—
0
$34.30
-$313,280.00
4.3K
Scheduled
Jun 16
Form 4
—
0
$32.70
-$287,680.00
4.3K
Scheduled
May 16
Form 4
—
0
$37.56
-$13,301,647.17
4.3K
Feb 13 - Feb 14
Form 4
—
0
—
—
0
Jan 21
Form 4
—
0
$23.63
-$582,500.00
0
Sep 6
Form 4
∞
4.3K
$14.70
-$816,687.70
4.3K
May 13
Form 4
—
0
$14.66
-$1,539,755.60
0
Feb 15
Form 4
—
0
—
—
0
Feb 9
Form 4
—
0
$15.86
-$425,552.00
0
Scheduled
Apr 27
Form 4
—
0
—
—
0
Jan 19
Form 4
—
0
—
—
0
Jan 25
Form 4
—
0
$11.25
-$366,708.34
0
Scheduled
Jan 18
Form 4
—
0
—
—
0
May 18
Form 4
—
0
$8.57
-$175,000.00
0
Mar 15
Form 4
—
0
—
—
0
Jan 21
Form 4
—
0
—
—
0
Jan 27
Form 3
—
0
—
—
0
No matching records found

MADRIGAL PHARMACEUTICALS, INC. (MDGL) Snapshot price: $243.89

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
$178.68
-$1,713,200.00
11.01K
Nov 7
Form 4
—
0
$154.15
-$1,467,903.41
11.01K
Nov 1
Form 4
+6.93%
714
—
—
11.01K
Jun 25
Form 4
—
0
$160.70
-$2,129,174.60
10.3K
Apr 1
Form 4
+13.16%
1.2K
—
—
10.3K
Jun 15
Form 4
—
0
$198.08
-$4,275,841.43
9.1K
Scheduled
Jan 17
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Jun 27
Form 4
—
0
—
—
0
Jun 19
Form 4
+28.17%
2K
$16.12
$32,235.91
9.1K
Aug 23
Form 4
+100.00%
3.55K
$16.12
$57,209.06
7.1K
Aug 22
Form 4
∞
3.55K
$15.88
$56,358.30
3.55K
Aug 21
Form 4
—
0
—
—
0
Jun 29
Form 4
—
0
—
—
0
Aug 11
Form 3
—
0
—
—
0
No matching records found

CONSTELLATION PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 15
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
Apr 3
Form 3
—
0
—
—
0
No matching records found

Kiniksa Pharmaceuticals, Ltd. (KNSA) Snapshot price: $24.93

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+51.30%
4.37K
—
—
12.9K
Jun 5 - Jun 6
Form 4
+9.61%
747
—
—
8.52K
May 3
Form 4
+55.54%
2.78K
—
—
7.78K
Nov 3
Form 4
∞
5K
—
—
5K
Jun 29
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Jun 29
Form 4
—
0
—
—
0
Jun 29
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Mar 4
Form 3
—
0
—
—
0
No matching records found

Kodiak Sciences Inc. (KOD) Snapshot price: $2.31

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 28
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Jun 8
Form 4
∞
1K
$44.33
$44,330.00
1K
Mar 20
Form 4
—
0
—
—
0
Jun 3
Form 3
—
0
—
—
0
No matching records found